Literature DB >> 17224650

p63, cellular senescence and tumor development.

Xuecui Guo1, Alea A Mills.   

Abstract

Deficiency of p63, a p53-related protein, causes severe defects in epithelial morphogenesis. Studies of p63-compromised mouse models reveal that p63 deficiency induces cellular senescence both in cultured cells and in vivo, through regulation p19(Arf)/p53 and p16(Ink4a)/Rb pathways. An extensive tumor study of p63-compromised mice demonstrated that p63 deficiency does not predispose to, but rather protects from, tumor development. These findings further implicate p63 as a negative regulator of the tumor suppressive mechanism of cellular senescence.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17224650     DOI: 10.4161/cc.6.3.3794

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  15 in total

1.  Distinct expression profiles of p63 variants during urothelial development and bladder cancer progression.

Authors:  Orit Karni-Schmidt; Mireia Castillo-Martin; Tian Huai Shen; Tian HuaiShen; Nataliya Gladoun; Josep Domingo-Domenech; Marta Sanchez-Carbayo; Yingchun Li; Scott Lowe; Carol Prives; Carlos Cordon-Cardo
Journal:  Am J Pathol       Date:  2011-03       Impact factor: 4.307

Review 2.  Therapy-induced senescence in cancer.

Authors:  Jonathan A Ewald; Joshua A Desotelle; George Wilding; David F Jarrard
Journal:  J Natl Cancer Inst       Date:  2010-09-21       Impact factor: 13.506

3.  Dual regulation of TERT activity through transcription and splicing by DeltaNP63alpha.

Authors:  Esther Vorovich; Edward A Ratovitski
Journal:  Aging (Albany NY)       Date:  2008-12-09       Impact factor: 5.682

4.  ATM kinase is a master switch for the Delta Np63 alpha phosphorylation/degradation in human head and neck squamous cell carcinoma cells upon DNA damage.

Authors:  Yiping Huang; Tanusree Sen; Jatin Nagpal; Sunil Upadhyay; Barry Trink; Edward Ratovitski; David Sidransky
Journal:  Cell Cycle       Date:  2008-09-15       Impact factor: 4.534

5.  Inactivation of the quinone oxidoreductases NQO1 and NQO2 strongly elevates the incidence and multiplicity of chemically induced skin tumors.

Authors:  Jun Shen; Roberto J Barrios; Anil K Jaiswal
Journal:  Cancer Res       Date:  2010-01-26       Impact factor: 12.701

6.  A microRNA-dependent circuit controlling p63/p73 homeostasis: p53 family cross-talk meets therapeutic opportunity.

Authors:  Benjamin Ory; Leif W Ellisen
Journal:  Oncotarget       Date:  2011-03

Review 7.  p73 as a pharmaceutical target for cancer therapy.

Authors:  Andrea Bisso; Licio Collavin; Giannino Del Sal
Journal:  Curr Pharm Des       Date:  2011       Impact factor: 3.116

8.  Androgen receptor drives cellular senescence.

Authors:  Yelena Mirochnik; Dorina Veliceasa; Latanya Williams; Kelly Maxwell; Alexander Yemelyanov; Irina Budunova; Olga V Volpert
Journal:  PLoS One       Date:  2012-03-05       Impact factor: 3.240

Review 9.  The foundational framework of tumors: Gametogenesis, p53, and cancer.

Authors:  Chunfang Liu; Asad Moten; Zhan Ma; Hui-Kuan Lin
Journal:  Semin Cancer Biol       Date:  2021-04-30       Impact factor: 17.012

10.  The alpha/beta carboxy-terminal domains of p63 are required for skin and limb development. New insights from the Brdm2 mouse which is not a complete p63 knockout but expresses p63 gamma-like proteins.

Authors:  S Wolff; F Talos; G Palacios; U Beyer; M Dobbelstein; U M Moll
Journal:  Cell Death Differ       Date:  2009-03-20       Impact factor: 15.828

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.